Scientific work

Uzm. Dr. Bülent Kantarcıoğlu

65 publications. The source of the information is stated next to each publication.

Back to profile

  1. The Role of Circulating MicroRNAs as Biomarkers and Therapeutic Targets in Venous Thromboembolism: A Systematic Review

    Journal of clinical medicine, 2026

    DOI 10.3390/jcm15166306 PMID 42652709 Open-access full textSource: Europe PMC

  2. Multifactorial thrombotic risk in Evans syndrome: a case report and review of the literature

    Thrombosis journal, 2026

    DOI 10.1186/s12959-026-00846-9 PMID 41736014 Open-access full textSource: Europe PMC

  3. Circulating Exosomal MicroRNAs as Potential Biomarkers for Pulmonary Embolism

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2026

    DOI 10.1177/10760296251407689 PMID 41773945 1 citation (Europe PMC) Open-access full textSource: Europe PMC

  4. Thromboinflammation and hemostatic activation drive early mortality risk in pulmonary embolism

    Research and Practice in Thrombosis and Haemostasis, 2026

    DOI 10.1016/j.rpth.2026.106633 PMID 42293734 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  5. PB2552 Cytokine-Driven and Immune-Inflammatory Signatures Predicts Early Mortality in Acute Pulmonary Embolism

    Research and Practice in Thrombosis and Haemostasis, 2026

    DOI 10.1016/j.rpth.2026.105292 Open-access full textSource: OpenAlex

  6. Plasminogen Activator Inhibitor-1 and Mean Platelet Volume as Potential Indicators of Prothrombotic State in Immune Thrombocytopenia: An Exploratory Study

    Medical Sciences, 2026

    DOI 10.3390/medsci14070712 Open-access full textSource: OpenAlex

  7. Charlson and Elixhauser Comorbidity Indices for Prediction of Mortality and Hospital Readmission in Patients With Acute Pulmonary Embolism

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2024

    DOI 10.1177/10760296241253844 PMID 38755956 6 citations (Europe PMC) Open-access full textSource: Europe PMC

  8. Decreased Thrombin Generation is Associated with Increased Thrombin Generation Biomarkers and Blood Cellular Indices in Pulmonary Embolism

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2024

    DOI 10.1177/10760296241261076 PMID 39043231 Open-access full textSource: Europe PMC

  9. Endogenous Dysregulation of Thromboinflammatory Biomarkers in End-Stage Renal Disease, and Their Amplification by Heart Failure

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2024

    DOI 10.1177/10760296241263858 PMID 39140866 1 citation (Europe PMC) Open-access full textSource: Europe PMC

  10. Vascular Endothelial Dysfunction and Immunothrombosis in the Pathogenesis of Atrial Fibrillation

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2024

    DOI 10.1177/10760296241296138 PMID 39654486 6 citations (Europe PMC) Open-access full textSource: Europe PMC

  11. Abstract 4146705: Thrombo-inflammatory biomarker and blood cellular indices are predictive of 30-day mortality Outcome in Patients with Acute Pulmonary Embolism

    Circulation, 2024

    DOI 10.1161/circ.150.suppl_1.4146705 1 citation (OpenAlex) Source: OpenAlex

  12. Relevance of Blood Cellular Indices with Inflammatory Cytokines in Patients with Pulmonary Embolism

    Blood, 2024

    DOI 10.1182/blood-2024-208723 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  13. Abstract 4141580: Prognostic value of blood cellular indices for 30-day mortality in patients with acute pulmonary embolism. Study from the RIETE Registry.

    Circulation, 2024

    DOI 10.1161/circ.150.suppl_1.4141580 Source: OpenAlex

  14. Ultrasound Accelerated Catheter Directed Thrombolytic Therapy in a 15-Year-old Pulmonary Embolism Patient with CLOVES Syndrome

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2023

    DOI 10.1177/10760296221149986 PMID 36650702 1 citation (Europe PMC) Open-access full textSource: Europe PMC

  15. The Relevance of Thrombo-Inflammatory Biomarkers and Their Relationship with Circulating Glycosaminoglycans in End-Stage Renal Disease Patients

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2023

    DOI 10.1177/10760296231169512 PMID 37062946 6 citations (Europe PMC) Open-access full textSource: Europe PMC

  16. Interrelationship Between Inflammatory Biomarkers and Collagen Remodeling Proteins in Atrial Fibrillation

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2023

    DOI 10.1177/10760296231165055 PMID 36941787 10 citations (Europe PMC) Open-access full textSource: Europe PMC

  17. Glycemic Control and Plasma Levels of Pro-Inflammatory and Pro-Thrombotic Biomarkers in Diabetic Patients Presenting with Acute Pulmonary Embolism

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2023

    DOI 10.1177/10760296231165058 PMID 36941804 6 citations (Europe PMC) Open-access full textSource: Europe PMC

  18. PB0121 Relationship of Thrombo-Inflammatory Biomarkers with Oxidative Stress Level in Non-Small Cell Lung Cancer Patients

    Research and Practice in Thrombosis and Haemostasis, 2023

    DOI 10.1016/j.rpth.2023.100928 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  19. INTERPLAY OF ADHESION MOLECULES WITH THROMBO-INFLAMMATORY PROCESSES IN PULMONARY EMBOLISM

    Journal of the American College of Cardiology, 2023

    DOI 10.1016/s0735-1097(23)02477-4 Open-access full textSource: OpenAlex

  20. #2728 THROMBOINFLAMMATORY BIOMARKERS AND THEIR RELATIONSHIP WITH CIRCULATING GLYCOSAMINOGLYCANS IN END-STAGE RENAL DISEASE PATIENTS

    Nephrology Dialysis Transplantation, 2023

    DOI 10.1093/ndt/gfad063c_2728 Open-access full textSource: OpenAlex

  21. INTERCONNECTION BETWEEN THROMBO-INFLAMMATORY AND OXIDATIVE STRESS-RELATED BIOMARKERS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER

    CHEST Journal, 2023

    DOI 10.1016/j.chest.2023.07.2759 Open-access full textSource: OpenAlex

  22. ENDOTHELIAL DYSREGULATION MEDIATORS IN MEDIATING HEMOSTATIC AND INFLAMMATORY IMBALANCE IN CANCER-ASSOCIATED THROMBOSIS

    CHEST Journal, 2023

    DOI 10.1016/j.chest.2023.07.3870 Open-access full textSource: OpenAlex

  23. Abstract P3021: Circulating Exosomal MicroRNAs As Biomarkers For Pulmonary Embolism

    Circulation Research, 2023

    DOI 10.1161/res.133.suppl_1.p3021 Source: OpenAlex

  24. PB1209 Thrombo-Inflammatory and Fibrinolytic Deficit Biomarkers and their Relationship with Circulating Glycosaminoglycans in End-Stage Renal Disease Patients

    Research and Practice in Thrombosis and Haemostasis, 2023

    DOI 10.1016/j.rpth.2023.101035 Open-access full textSource: OpenAlex

  25. PB1327 Bioequivalence of a Generic Version of rFVIIa (Aryoseven) as Compared to the Branded Version of rFVIIa (Novoseven)

    Research and Practice in Thrombosis and Haemostasis, 2023

    DOI 10.1016/j.rpth.2023.101239 Open-access full textSource: OpenAlex

  26. PB1018 Inter-Relationship of Adhesion Molecules with Thrombo-Inflammatory Processes in Pulmonary Embolism

    Research and Practice in Thrombosis and Haemostasis, 2023

    DOI 10.1016/j.rpth.2023.101816 Open-access full textSource: OpenAlex

  27. PB0968 Thrombo-Inflammatory Biomarkers and Coagulation Factors Contributes to the Hypercoagulable State in Lung Cancer Patients

    Research and Practice in Thrombosis and Haemostasis, 2023

    DOI 10.1016/j.rpth.2023.101724 Open-access full textSource: OpenAlex

  28. PB0452 Glycemic Control and Plasma Levels of Pro-Inflammatory and Pro- Thrombotic Biomarkers in Diabetic Patients Presenting with Acute Pulmonary Embolism

    Research and Practice in Thrombosis and Haemostasis, 2023

    DOI 10.1016/j.rpth.2023.101808 Open-access full textSource: OpenAlex

  29. Abstract 16961: Characterization of Extracellular Vesicles and RNA Content and Its Relevance to Thrombo-Inflammatory Biomarkers in Patients With Acute Pulmonary Embolism

    Circulation, 2023

    DOI 10.1161/circ.148.suppl_1.16961 Source: OpenAlex

  30. Abstract 16964: Predictive Value of Blood Cellular Indices for 30-day Mortality in Patients With Acute Pulmonary Embolism. Data From the RIETE Registry

    Circulation, 2023

    DOI 10.1161/circ.148.suppl_1.16964 Source: OpenAlex

  31. Differences in Vascular Access Can Influence the Level of Thrombo-Inflammation and Oxidative Stress in Patients with Hemodialysis

    Journal of the American Society of Nephrology, 2023

    DOI 10.1681/asn.20233411s1540b Source: OpenAlex

  32. Duration of Hemodialysis as an Amplifier of Thrombolytic Deficit and Oxidative Stress in ESRD

    Journal of the American Society of Nephrology, 2023

    DOI 10.1681/asn.20233411s1889c Source: OpenAlex

  33. The Relevance of Anti-PF4 Antibody Isotypes and Endogenous Glycosaminoglycans and their Relationship with Inflammatory Biomarkers in Pulmonary Embolism Patients

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2022

    DOI 10.1177/10760296221091770 PMID 35360982 4 citations (Europe PMC) Open-access full textSource: Europe PMC

  34. Collagen Remodeling and Fatty Acid Regulation Biomarkers in Understanding the Molecular Pathogenesis of Atrial Fibrillation

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2022

    DOI 10.1177/10760296221145181 PMID 36514257 7 citations (Europe PMC) Open-access full textSource: Europe PMC

  35. Predictive Role of Blood Cellular Indices and Their Relationship with Endogenous Glycosaminoglycans as Determinants of Inflammatory Biomarkers in Pulmonary Embolism

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2022

    DOI 10.1177/10760296221104801 PMID 35733366 6 citations (Europe PMC) Open-access full textSource: Europe PMC

  36. Endogenous Glycosaminoglycans in Various Pathologic Plasma Samples as Measured by a Fluorescent Quenching Method

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2022

    DOI 10.1177/10760296221144047 PMID 36474353 3 citations (Europe PMC) Open-access full textSource: Europe PMC

  37. An Update on the Status of Vaccine Development for SARS-CoV-2 Including Variants. Practical Considerations for COVID-19 Special Populations

    Clinical and Applied Thrombosis/Hemostasis, 2022

    DOI 10.1177/10760296211056648 PMID 35167393 24 citations (OpenAlex) Open-access full textSource: OpenAlex

  38. Cellular Indices and Outcome in Patients with Acute Venous Thromboembolism

    Clinical and Applied Thrombosis/Hemostasis, 2022

    DOI 10.1177/10760296221113346 PMID 35866197 19 citations (OpenAlex) Open-access full textSource: OpenAlex

  39. Differential Neutralization of Apixaban, Betrixaban, Edoxaban, and Rivaroxaban by Andexanet Alfa as Measured by Whole Blood Thromboelastographic Analysis

    Clinical and Applied Thrombosis/Hemostasis, 2022

    DOI 10.1177/10760296221138297 PMID 36476125 5 citations (OpenAlex) Open-access full textSource: OpenAlex

  40. Development and Implementation of an Online Global Pharmacovigilance Certificate Program During the COVID-19 Pandemic

    Clinical and Applied Thrombosis/Hemostasis, 2022

    DOI 10.1177/10760296221115112 PMID 35848566 2 citations (OpenAlex) Open-access full textSource: OpenAlex

  41. Safety and efficacy of currently used COVID‐19 vaccines: Results of a pilot survey

    The FASEB Journal, 2022

    DOI 10.1096/fasebj.2022.36.s1.r3664 1 citation (OpenAlex) Open-access full textSource: OpenAlex

  42. Bio‐equivalence of Potency Adjusted Approved Heparin Solutions Compared to a Newly Developed Heparin Solution

    The FASEB Journal, 2022

    DOI 10.1096/fasebj.2022.36.s1.r4995 Source: OpenAlex

  43. Molecular Systems Network Predicts Sars-Cov-2 NSP3 and Orf6 Role in COVID-19 Related Thrombotic Events

    Blood, 2022

    DOI 10.1182/blood-2022-168365 Open-access full textSource: OpenAlex

  44. The Impact of Glycemic Control in Thrombo-Inflammatory Biomarkers in Diabetic Pulmonary Embolism Patients

    Blood, 2022

    DOI 10.1182/blood-2022-165694 Source: OpenAlex

  45. Endogenous Thrombin Generation Potential in Patients with Pulmonary Embolism and Its Relevance to Thrombo-Inflammatory Biomarkers

    Blood, 2022

    DOI 10.1182/blood-2022-165810 Source: OpenAlex

  46. The Role of Blood Cellular Indices in Diabetic Pulmonary Embolism Patients in Predicting Adverse Outcomes

    Blood, 2022

    DOI 10.1182/blood-2022-165765 Source: OpenAlex

  47. A Generic Version of rFVIIa Is Bioequivalent to the Branded Version of rFVIIa

    Blood, 2022

    DOI 10.1182/blood-2022-170935 Source: OpenAlex

  48. Abstract 10876: Thrombo-Inflammatory Biomarkers in Pulmonary Embolism as Stratified in Cancer and Non-Cancer Patient Groups

    Circulation, 2022

    DOI 10.1161/circ.146.suppl_1.10876 Source: OpenAlex

  49. Thromboinflammatory Biomarkers and Their Relationship With Circulating Glycosaminoglycans in ESRD Patients

    Journal of the American Society of Nephrology, 2022

    DOI 10.1681/asn.20223311s1712c Source: OpenAlex

  50. Public Perceptions of Current COVID-19 Vaccinations. Results of a Pilot Survey

    Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis, 2021

    DOI 10.1177/10760296211066942 PMID 34905980 4 citations (Europe PMC) Open-access full textSource: Europe PMC